Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linwah Yip

Showing results (121-130 of 168) with videos related to

Pageof 17
Sort By:
Surgery|December 3, 2014
Surgeon volume and adequacy of thyroidectomy for differentiated thyroid cancerCameron D Adkisson, Gina M Howell, Kelly L McCoy, et al.
Surgery|December 5, 2009
Optimizing surgical treatment of papillary thyroid carcinoma associated with BRAF mutationLinwah Yip, Marina N Nikiforova, Sally E Carty, et al.
Surgery|October 9, 2024
Tumor size and molecular risk group are associated with differentiated thyroid cancer recurrenceSaba Kurtom, Jason B Liu, William R Doerfler, et al.
Cancer Cytopathology|January 26, 2010
Contribution of molecular testing to thyroid fine-needle aspiration cytology of "follicular lesion of undetermined significance/atypia of undetermined significance"N Paul Ohori, Marina N Nikiforova, Karen E Schoedel, et al.
Journal of the American College of Surgeons|July 7, 2012
Intraoperative pathologic examination in the era of molecular testing for differentiated thyroid cancerKelly L McCoy, Sally E Carty, Michaele J Armstrong, et al.
Archives of Surgery (Chicago, Ill. : 1960)|April 11, 2003
Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationshipLinwah Yip, Gilbert J Cote, Suzanne E Shapiro, et al.
Endocrine-Related Cancer|October 15, 2024
Reappraisal of BRAFK601E-positive thyroid tumors in the NIFTP eraWilliam R Doerfler, Alyaksandr V Nikitski, Shannon Keating, et al.
Cancer Cytopathology|August 14, 2012
BRAF mutation detection in indeterminate thyroid cytology specimens: underlying cytologic, molecular, and pathologic characteristics of papillary thyroid carcinomaN Paul Ohori, Rashi Singhal, Marina N Nikiforova, et al.
Cancer|February 4, 2021
Risk assessment for distant metastasis in differentiated thyroid cancer using molecular profiling: A matched case-control studyLinwah Yip, William E Gooding, Alyaksandr Nikitski, et al.
Annals of Surgical Oncology|May 20, 2011
Both BRAF V600E mutation and older age (≥ 65 years) are associated with recurrent papillary thyroid cancerGina M Howell, Sally E Carty, Michaele J Armstrong, et al.
Pageof 17

Showing results (121-130 of 168) with videos related to

Sort By:
Pageof 17
Surgery|December 3, 2014
Surgeon volume and adequacy of thyroidectomy for differentiated thyroid cancerCameron D Adkisson, Gina M Howell, Kelly L McCoy, et al.
Surgery|December 5, 2009
Optimizing surgical treatment of papillary thyroid carcinoma associated with BRAF mutationLinwah Yip, Marina N Nikiforova, Sally E Carty, et al.
Surgery|October 9, 2024
Tumor size and molecular risk group are associated with differentiated thyroid cancer recurrenceSaba Kurtom, Jason B Liu, William R Doerfler, et al.
Cancer Cytopathology|January 26, 2010
Contribution of molecular testing to thyroid fine-needle aspiration cytology of "follicular lesion of undetermined significance/atypia of undetermined significance"N Paul Ohori, Marina N Nikiforova, Karen E Schoedel, et al.
Journal of the American College of Surgeons|July 7, 2012
Intraoperative pathologic examination in the era of molecular testing for differentiated thyroid cancerKelly L McCoy, Sally E Carty, Michaele J Armstrong, et al.
Archives of Surgery (Chicago, Ill. : 1960)|April 11, 2003
Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationshipLinwah Yip, Gilbert J Cote, Suzanne E Shapiro, et al.
Endocrine-Related Cancer|October 15, 2024
Reappraisal of BRAFK601E-positive thyroid tumors in the NIFTP eraWilliam R Doerfler, Alyaksandr V Nikitski, Shannon Keating, et al.
Cancer Cytopathology|August 14, 2012
BRAF mutation detection in indeterminate thyroid cytology specimens: underlying cytologic, molecular, and pathologic characteristics of papillary thyroid carcinomaN Paul Ohori, Rashi Singhal, Marina N Nikiforova, et al.
Cancer|February 4, 2021
Risk assessment for distant metastasis in differentiated thyroid cancer using molecular profiling: A matched case-control studyLinwah Yip, William E Gooding, Alyaksandr Nikitski, et al.
Annals of Surgical Oncology|May 20, 2011
Both BRAF V600E mutation and older age (≥ 65 years) are associated with recurrent papillary thyroid cancerGina M Howell, Sally E Carty, Michaele J Armstrong, et al.
Pageof 17